Abnormal expression of P2X family receptors in Chinese pediatric acute leukemias

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 498-504

  Chong, Jing Hui ^a   Zheng, Guo Guang ^a   Zhu, Xiao Fan ^a   Guo, Ye ^a   Wang, Lin ^a   Ma, Cui Hua ^a   Liu, Shu Yan ^a   Xu, Lin Lin ^a   Lin, Yong Min ^a   Wu, Ke Fu ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Expression; P2X; Pediatric acute leukemia; Receptor; Therapy

Indexed keywords

COMPLEMENTARY DNA; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X5 RECEPTOR; PURINERGIC P2X6 RECEPTOR; PURINERGIC P2X7 RECEPTOR;

ARTICLE; BONE MARROW BIOPSY; CHILD; CHILDHOOD LEUKEMIA; CHINESE; CONTROLLED STUDY; FOLLOW UP; GENE OVEREXPRESSION; GENE SYNTHESIS; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; HUMANS; LEUKEMIA; RECEPTORS, PURINERGIC P2; TUMOR MARKERS, BIOLOGICAL;

EID: 73149124913     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.11.087     Document Type: Article

References (32)

1. Pellegatti P., Raffaghello L., Bianchi G., Piccardi F., Pistoia V., and Di Virgilio F. Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 3 (2008) e2599
2. Barnard E.A., Burnstock G., and Webb T.E. G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol. Sci. 15 (1994) 67-70
3. Valera S., Hussy N., Evans R.J., Adami N., North R.A., Surprenant A., and Buell G. A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP. Nature 371 (1994) 516-519
4. Khakh B.S., and North R.A. P2X receptors as cell-surface ATP sensors in health and disease. Nature 442 (2006) 527-532
5. Labasi J.M., Petrushova N., Donovan C., McCurdy S., Lira P., Payette M.M., et al. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168 (2002) 6436-6445
6. White N., and Burnstock G. P2 receptors and cancer. Trends Pharmacol. Sci. 27 (2006) 211-217
7. Solini A., Cuccato S., Ferrari D., Santini E., Gulinelli S., Callegari M.G., et al. Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease?. Endocrinology 149 (2008) 389-396
8. Koles L., Gerevich Z., Oliveira J.F., Zadori Z.S., Wirkner K., and Illes P. Interaction of P2 purinergic receptors with cellular macromolecules. Naunyn Schmiedebergs Arch Pharmacol. 377 (2008) 1-33
9. Mahaut-Smith M.P., Tolhurst G., and Evans R.J. Emerging roles for P2X1 receptors in platelet activation. Platelets 15 (2004) 131-144
10. Berchtold S., Ogilvie A.L., Bogdan C., Muhl-Zurbes P., Ogilvie A., Schuler G., and Steinkasserer A. Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases. FEBS Lett. 458 (1999) 424-428
11. Wang L., Jacobsen S.E., Bengtsson A., and Erlinge D. P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol. 5 (2004) 16
12. Di Virgilio F., Chiozzi P., Ferrari D., Falzoni S., Sanz J.M., Morelli A., et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97 (2001) 587-600
13. Adinolfi E., Melchiorri L., Falzoni S., Chiozzi P., Morelli A., Tieghi A., et al. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99 (2002) 706-708
14. Zhang X.J., Zheng G.G., Ma X.T., Yang Y.H., Li G., Rao Q., et al. Expression of P2X7 in human hematopoietic cell lines and leukemia patients. Leuk. Res. 28 (2004) 1313-1322
15. Nie K., Zheng G.G., Zhang X.J., Lin Y.M., Wang L., Li G., et al. CD39-associated high ATPase activity contribute to the loss of P2X7-mediated calcium response in LCL cells. Leuk. Res. 29 (2005) 1325-1333
16. Pui C.H., Sandlund J.T., Pei D., Campana D., et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood 104 (2004) 2690-2696
17. Kaspers G.J., and Zwaan C.M. Pediatric acute myeloid leukemia: towards high-quality cure of all patients. Haematologica 92 (2007) 1519-1532
18. Wu K.F., Rao Q., Zheng G.G., Geng Y.Q., Li M., Kong J., et al. Enhancement of J6-1 human leukemic cell proliferation by cell-cell contact: role of an M-CSF-like membrane-associated growth factor MAF-J6-1. Leuk. Res. 18 (1994) 843-849
19. Burnstock G. Purinergic signalling: past, present and future. Braz. J. Med. Biol. Res. 42 (2009) 3-8
20. Bourne G.H. One hundred volumes of the international review of cytology. Int. Rev. Cytol. 100 (1987) 1-13
21. Nicke A., Kerschensteiner D., and Soto F. Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits. J. Neurochem. 92 (2005) 925-933
22. Lalo U., Pankratov Y., Wichert S.P., Rossner M.J., North R.A., Kirchhoff F., and Verkhratsky A. P2X1 and P2X5 subunits form the functional P2X receptor in mouse cortical astrocytes. J. Neurosci. 28 (2008) 5473-5480
23. Guo C., Masin M., Qureshi O.S., and Murrell-Lagnado R.D. Evidence for functional P2X4/P2X7 heteromeric receptors. Mol. Pharmacol. 72 (2007) 1447-1456
24. Baricordi O.R., Melchiorri L., Adinolfi E., Falzoni S., Chiozzi P., Buell G., and Di Virgilio F. Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. J. Biol. Chem. 274 (1999) 33206-33208
25. Di Virgilio F., Chiozzi P., Falzoni S., Ferrari D., Sanz J.M., Venketaraman V., and Baricordi O.R. Cytolytic P2X purinoceptors. Cell Death Differ. 5 (1998) 191-199
26. Di Virgilio F., Ferrari D., and Adinolfi E. P2X(7): a growth-promoting receptor-implications for cancer. Purinergic Signal. 5 (2009) 251-256
27. Raffaghello L., Chiozzi P., Falzoni S., Di Virgilio F., and Pistoia V. The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. Cancer Res. 66 (2006) 907-914
28. Adinolfi E., Callegari M.G., Ferrari D., Bolognesi C., Minelli M., Wieckowski M.R., Pinton P., Rizzuto R., and Di Virgilio F. Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol. Biol. Cell 16 (2005) 3260-3272
29. Humphreys B.D., Rice J., Kertesy S.B., and Dubyak G.R. Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J. Biol. Chem. 275 (2000) 26792-26798
30. Gendron F.P., Neary J.T., Theiss P.M., Sun G.Y., Gonzalez F.A., and Weisman G.A. Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am. J. Physiol. Cell Physiol. 284 (2003) C571-C581
31. Pfeiffer Z.A., Aga M., Prabhu U., Watters J.J., Hall D.J., and Bertics P.J. The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho. J. Leukoc. Biol. 75 (2004) 1173-1182
32. Pochet S., Gomez-Munoz A., Marino A., and Dehaye J.P. Regulation of phospholipase D by P2X7 receptors in submandibular ductal cells. Cell Signal. 15 (2003) 927-935